annual report, page-2

Hi scooter99

PRR always seems to re-issue the Annual Report at the same time as they announce the date for the AGM, in a more reader friendly format

The original Annual Report was actually published on the 30th August in the Appendix 4E announcement, so clearly some of the information is now obsolete, post the CAN003 trial results.

Not really sure why they choose to do it this way. It's what confused me a few days ago.

Hopefully by the AGM they should have a strategic update for us.

Interesting to read on the new PRR website they are putting much emphasis on "Partnering".


Business Development
Prima BioMed is committed to building a portfolio of treatments based on personalized bio-therapeutics.

Collaboration and Licensing Opportunities
Prima BioMed is actively seeking potential collaboration or licensing opportunities in oncology that would complement our existing portfolio and technology platform. We are also interested in novel therapeutic opportunities in other disease areas and with a cellular immunotherapeutic background. Our lead program, CVac™ and unique platform technology makes us an attractive partnering candidate.

We welcome inquiries from corporations, individuals, and academic institutions.